Drug/Medical Device
The Procter & Gamble Company (PG)
| Date: | Mar 14, 2006 |
|---|---|
| Format: | HTML |
| Price: | $70.00 |
Abstract
The The Procter & Gamble Company (PG) Drug/Medical Device report provides unparalleled insights into its performance and risk through making available 3 key pieces of data: (1) product/candidate pipeline, (2) product/candidate regulatory status, and (3) product/candidate pipeline diversification. The report includes a detailed presentation of each drug/device candidate's indication, its clinical trial status (i.e. preclinical, Phase 1, Phase 2, Phase 3, NDA/BLA Filed, IDE Filed, 510K/PMA Filed, Approvable Letter Received), and its mechanism of action. In addition, the report identifies the strategic disease focus of The Procter & Gamble Company and outlines its pipeline diversification across various disease sectors and sub-sectors (i.e. Cardiology, Oncology, Neurology, Immunology, Urology, etc.).
Report Contents
- Overview
- Product Summary
- Business Description
- Technical Summary
- Company Highlights
- Drug/Medical Device Details
- Industry/Sector Participation
- Product details
- Indications/Side Effects/Approval Details
Companies Mentioned in the Report
More Information:
Learn more about Drug/Medical Device Report.